Abstract: A centralized, online clinical study system configured to coordinate aspects of a clinical study can include a training module configured to evaluate whether users have completed training for selected workflows for the clinical study that are available from the clinical study system, and to provide training to registered users for the selected workflows. The system also can include a financial engine configured to determine when a participating site meets or exceeds a milestone of the clinical study and to initiate a payment to the participating site. Further, the system can include a module configured to receive and verify clinical research data and to designate the verified clinical research data as official source data for the clinical study.

Abstract: The present invention relates to a method for determining the number of copies of DNA at a specific locus. The method comprises the step of co-amplifying a DNA sample of an exploratory species comprising the test locus with a competitor sample comprising an orthologous DNA sequence derived from a closely related species.

Abstract: A panel and method of making a panel is disclosed. One described panel comprises a core comprising a flat region and a contoured region, wherein the contoured region comprises a convex feature, a first adjacent base and a second adjacent base, the apex of the convex feature has a first caliper, the first adjacent base has a second caliper smaller than the first caliper, and the second adjacent base has a third caliper smaller than the first caliper.

Abstract: A centralized, online clinical study system configured to coordinate aspects of a clinical study can include a training module configured to evaluate whether users have completed training for selected workflows for the clinical study that are available from the clinical study system, and to provide training to registered users for the selected workflows. The system also can include a financial engine configured to determine when a participating site meets or exceeds a milestone of the clinical study and to initiate a payment to the participating site. Further, the system can include a module configured to receive and verify clinical research data and to designate the verified clinical research data as official source data for the clinical study.

Abstract: A bird feeder includes a support, a body including at least one feeding station which is rotatably mounted to the support such that said body can be oriented in a feeding position and a refilling position, said body including a receiving chamber with an opening and a scoop which is receivable through the opening for at least partial accommodation in the receiving chamber. To refill the feeder, the scoop is removed from the body to scoop a quantity of feed. The scoop is then inserted, open end first, upwardly into the downwardly facing opening in the chamber with the body in the refilling position. The body is then pivoted back to the feeding position. Operation of gravity thereby transfers the feed contained in the scoop to at least one feeding station, which can simply be one or more openings, located in the body of the feeder at a position below the open end of the scoop received in the chamber.

Abstract: A centralized, online clinical study system configured to coordinate aspects of a clinical study can include a training module configured to evaluate whether users have completed training for selected workflows for the clinical study that are available from the clinical study system, and to provide training to registered users for the selected workflows. The system also can include a financial engine configured to determine when a participating site meets or exceeds a milestone of the clinical study and to initiate a payment to the participating site. Further, the system can include a module configured to receive and verify clinical research data and to designate the verified clinical research data as official source data for the clinical study.

Abstract: The present invention provides a novel pharmaceutical composition for the treatment of breast cancer. Also provided are various methods of treating breast cancer.

Abstract: The invention relates to a peptide, characterized in that it corresponds to the following sequence of amino acids:Xaa.sub.1 Pro Xaa.sub.2 Pro Xaa.sub.3 Xaa.sub.4 Phe Tyr Gly Leu Metin which a.sub.n with n equal to 1, 2, 3 or 4 represents any amino acid, and in particular in that the peptide is ranakinin having the following formula:Lys Pro Asn Pro Glu Arg Phe Tyr Gly Leu MetThe invention also relates to the use of this peptide in pharmacological applications.